Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,550,000
+$9,887,532 QoQ
Shares Held
660,000
-29.6% QoQ
Ownership
2.27%
of shares outstanding
% of Portfolio
4.29%
of 13F equity value
Holder Rank
#10
of 211 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names. ANAB ranks #1 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANAB |
Anaptysbio, Inc
This page
|
660,000 | $44,550,000 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
290,000 | $35,548,200 | |
| 3 | MGTX |
MeiraGTx Holdings plc
|
2,300,000 | $31,073,000 | |
| 4 | WVE |
Wave Life Sciences, Inc.
|
4,950,000 | $28,759,500 | |
| 5 | QURE |
uniQure N.V.
|
575,000 | $26,484,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
389,081 | $21,376,110 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,072,500 | |
| 8 | TRAX |
First Tracks Biotherapeutics, Inc.
|
750,000 | $15,090,000 |
All Filings in ANAB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,550,000 | 660,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $34,662,468 | 625,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $31,419,548 | 648,093 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,749,112 | 547,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,100,000 | 500,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,636,696 | 195,627 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||